Journal of Internal Medicine Concepts & Practice >
Analysis of knowledge depth and breadth of understanding chronic heart failure in general practitioners in Shanghai and influencing factors
Received date: 2022-05-09
Online published: 2023-02-27
Objective To investigate the knowledge depth and breadth of understanding the chronic heart failure in general practitioners in Shanghai community healthcare center, analyze the influencing factors, and to provide a scientific basis for the prevention and treatment of heart failure in the future. Methods Based on the“Guidelines for Primary Diagnosis and Treatment of Chronic Heart Failure (2019)”, a questionnaire was designed, and it covered the definition and epidemiology of heart failure, etiology and pathogenesis, diagnostic evaluation, drug therapy, and non-drug management. The questionnaire was conducted on general practitioners working in 10 community health service centers in Shanghai from May to June 2021, the demographic characteristics of the study subjects was collected, the knowledge depth and breadth of understanding chronic heart failure was investigated, and the influencing factors were analyzed. Results The average score of 136 primary doctors on the knowledge test of heart failure was (63.5±11.2) points, and the pass rate was 52.2%(71/136); in which, the correct rate of understanding the heart failure of preserved ejection fraction, the use of three new anti-heart failure drugs, the vulnerable period of heart failure and the management of water and sodium were less than 50 percent, while the remaining parts was greater than 50.0%. Consulting with a cardiologist, participating the heart failure-related training in past 2 years, and studying the“Guidelines” were independent influencing factors(P<0.05). Conclusions This study showed that the general practitioners in Shanghai overall have a good understanding of chronic heart failure knowledge, but they still need to improve understanding of heart failure of preserved ejection fraction, the use of new anti-heart failure drugs, and the comprehensive management of heart failure patients.
ZHANG Ruixin, QU Chunyan, JIANG Jie, TONG Jianjing . Analysis of knowledge depth and breadth of understanding chronic heart failure in general practitioners in Shanghai and influencing factors[J]. Journal of Internal Medicine Concepts & Practice, 2022 , 17(06) : 457 -462 . DOI: 10.16138/j.1673-6087.2022.06.007
[1] | Shah KS, Xu H, Matsouaka RA, et al. Heart failure with preserved, borderline, and reduced ejection fraction[J]. J Am Coll Cardiol, 2017, 70(20): 2476-2486. |
[2] | Estep JD. Chronic heart failure: what does the horizon look like?[J]. Curr Opin Cardiol, 2015, 30(4): 344-353. |
[3] | ?pinar J, ?pinarová L, Vítovec J. Pathophysiology, causes and epidemiology of chronic heart failure[J]. Vnitr Lek, 2018, 64(9): 834-838. |
[4] | Wang J, Li W. Self-care education program improves quality of life in patients with chronic heart failure[J]. Medicine (Baltimore), 2020, 99(50): e23621. |
[5] | Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals[J]. Lancet, 2018, 391(10120): 572-580. |
[6] | Hua CY, Huang Y, Su YH, et al. Collaborative care model improves self-care ability, quality of life and cardiac function of patients with chronic heart failure[J]. Braz J Med Biol Res, 2017, 50(11): e6355. |
[7] | 黄峻. 中国心力衰竭流行病学特点和防治策略[J]. 中华心脏与心律电子杂志, 2015, 3(2): 2-3. |
[8] | 甘天翊, 刘妮妮, 张宇辉, 等. 内科医生对心力衰竭指南知识的掌握情况调查[J]. 中国循环杂志, 2017, 32(10): 952-955. |
[9] | Loai S, Cheng HM. Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging[J]. Heart Fail Rev, 2020, 25(2): 305-319. |
[10] | 刘长清, 樊光辉. 射血分数保留的心力衰竭合并2型糖尿病患者的临床特征分析[J]. 中国心血管杂志, 2018, 23(3): 251-255. |
[11] | McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure[J]. N Engl J Med, 2014, 371(11): 993-1004. |
[12] | 孙科远, 黄高忠, 袁方, 等. 缺氧诱导因子1α在慢性心力衰竭急性失代偿诊断及预后判断中的价值[J]. 上海交通大学学报(医学版), 2018, 38(4): 426 -429. |
[13] | 苟怀宇, 陈艳秋, 吴哓玲. 伊伐布雷定对急性失代偿性收缩性心力衰竭患者左心室收缩和舒张功能的影响[J]. 临床内科杂志, 2018, 35(10): 711-712. |
[14] | 陆艳, 陆媛. 伊伐布雷定联合沙库巴曲缬沙坦治疗心力衰竭的临床效果[J]. 临床医学研究与实践, 2022, 7(5): 46-49. |
[15] | McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2019, 381(21): 1995-2008. |
[16] | 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 慢性心力衰竭基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(10): 936-947. |
[17] | Zannad F, Ferreira JP, Pocock SJ, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials[J]. Lancet, 2020, 396(10254): 819-829. |
[18] | Saitoh M, Dos Santos MR, Ebner N, et al. Nutritional status and its effects on muscle wasting in patients with chronic heart failure[J]. Wien Klin Wochenschr, 2016, 128 Suppl 7: 497-504. |
[19] | Bonilla Palomas JL, Gámez López AL, Moreno Conde M, et al. Impact of malnutrition on long-term mortality in outpatients with chronic heart failure[J]. Nutr Hosp, 2017, 34(5): 1382-1389. |
[20] | 杨芸峰, 徐莉苹, 顾文钦, 等. “全专结合”医疗模式在社区卫生服务机构中应用的思考与实践[J]. 中华全科医师杂志, 2018, 17(9): 679-682. |
[21] | 黄桂琼, 洪晓华, 周俏棋, 等. 医院与社区联合进行慢性心力衰竭中西医结合专病管理模式的探索[J]. 中国当代医药, 2016, 23(35): 156-158. |
[22] | 王欣玲, 许嘉鸿. 慢性心力衰竭患者的医院-社区联合双向管理模式研究[J]. 国际心血管病杂志, 2017, 44(3): 189-191. |
/
〈 |
|
〉 |